FDA grants priority review for Gilead HIV drug
If the sNDA is approved, Truvada would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV, the company said. The sNDA is
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The communications technology solution platform will bring together existing but isolated communications and healthcare IT infrastructure investments, the company said. The platform will leverage existing hospital and clinical